Health issues specific to women may influence Parkinson’s severity
Certain experiences particular to women, from a natural childbirth or pregnancy-related depression to a hysterectomy, could cause their Parkinson’s…
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Certain experiences particular to women, from a natural childbirth or pregnancy-related depression to a hysterectomy, could cause their Parkinson’s…
NeuroOne Medical Technologies is seeking approval from the U.S. Food and Drug Administration (FDA) for its OneRF ablation…
Testing for the presence of misfolded alpha-synuclein — the protein that toxically builds up in Parkinson’s disease — in…
Long-term treatment with sargramostim, an immune-modulating medication from Partner Therapeutics, was safe and improved motor function for…
An experimental molecule called ONO-2506 was found to reduce the occurrence of abnormal movements — dyskinesia — resulting from early…
Researchers have identified certain pesticides used in agricultural settings that were linked to Parkinson’s disease risk among people living…
A new review study found limited evidence that exercise may be beneficial in slowing Parkinson’s disease progression, as assessed…
Parkinson’s disease patients in Japan reported a general worsening of their symptoms and less time spent out of the…
People with post-traumatic stress disorder (PTSD) were found to be at a higher risk of Parkinson’s disease or related…
Supernus Pharmaceuticals plans to resubmit its application seeking approval of SPN-830, its apomorphine infusion pump for people with…
Get regular updates to your inbox.